FIP1L1-PDGFRA GENE REARRANGEMENT

This test detects a gene rearrangement involving FIP1L1 and PDGFRA, which is associated with certain forms of leukemia. It helps in diagnosing myeloproliferative diseases, particularly chronic eosinophilic leukemia. The rearrangement is a target for specific treatments.

Also known asFip1l1-pdgfra Gene Rearrangement Fip1l1-pdgfra Gene Rearrangement

Available via

Home Collection, Lab Visit

Contains

3 parameters

Earliest reports in

7 Working Days

Test details

FIP1L1-PDGFRA GENE REARRANGEMENT Test in Vadodara Overview

Preparations

No special preparations needed

Test included
FIP1L1-PDGFRA GENE REARRANGEMENT includes 3 parameters

  • Specimen Source
  • Preliminary Report
  • Fip1l1-pdgfra Gene Rearrangement
Frequently Asked Questions

 This test detects the FIP1L1-PDGFRA fusion gene, which is associated with certain eosinophilic disorders, including hypereosinophilic syndrome and eosinophilic leukemia.

 It helps diagnose PDGFRA-associated eosinophilic disorders and guides treatment decisions, particularly the use of tyrosine kinase inhibitors.

 A blood or bone marrow sample is analyzed using PCR or fluorescence in situ hybridization (FISH) to detect the gene fusion.

 A positive result confirms the presence of a PDGFRA-associated disorder, which responds well to imatinib therapy.

 Treatment with targeted therapy and regular blood count monitoring is usually recommended.

Test code

RD1314

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Bone MarrowOthers1 ML
Edta Whole BloodLavender Vacutainer3 ML

Specimen stability information

Bone Marrow, Edta Whole Blood

Collection instructions

Clinical History

Specimen rejection criteria

Test run frequency

Every Day TIME - 09:30

Turn around time

7 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

FIP1L1-PDGFRA GENE REARRANGEMENT

6700